Titan Biotech Limited (BOM:524717)
1,108.20
+75.95 (7.36%)
At close: Feb 11, 2026
Titan Biotech Market Cap
Titan Biotech has a market cap or net worth of 9.4 billion as of February 12, 2026. Its market cap has increased by 53.91% in one year.
Market Cap
9.40B
Enterprise Value
9.46B
Revenue
1.74B
Ranking
n/a
PE Ratio
40.78
Stock Price
1,108.20
Market Cap Chart
Since December 22, 2000, Titan Biotech's market cap has increased from 100.53M to 9.40B, an increase of 9,253.93%. That is a compound annual growth rate of 19.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 9.40B | 7.98% |
| Dec 31, 2025 | 8.71B | 43.81% |
| Dec 31, 2024 | 6.06B | 78.89% |
| Dec 29, 2023 | 3.38B | 37.68% |
| Dec 30, 2022 | 2.46B | 0.42% |
| Dec 31, 2021 | 2.45B | 98.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dhanlaxmi Bank | 9.54B |
| The Yamuna Syndicate | 9.53B |
| TAAL Tech | 9.50B |
| GRP Limited | 9.44B |
| Amines & Plasticizers | 9.41B |
| Borosil Scientific | 9.41B |
| Om Infra | 9.34B |
| Saint-Gobain Sekurit India | 9.33B |